Jennifer Kang-Mieler (jkangmie)

Jennifer Kang-Mieler

Professor and Chair of the Department of Biomedical Engineering

Research

Ocular drug delivery systems, Retinal imaging, Biomarkers, Retinal hemodynamics and electrophysiology

General Information

Dr. Kang-Mieler’s translational NIH-supported research projects include ocular drug delivery, retinal imaging and biomarkers, retinal blood flow, and electrophysiology. Her clinical interests include retinal vascular diseases such as age-related macular degeneration and diabetic retinopathy.

Experience

Education:
Northwestern University, Evanston IL
B.A. in Mathematics
M.S. in Applied Mathematics
Ph.D. in Biomedical Engineering

University of Illinois at Chicago, Chicago, IL
Post-doctoral research, Department of Ophthalmology and Visual Sciences

Honors and Awards

Walter P. Murphy Fellowship, Graduate Fellowship, Northwestern University

General Electric Faculty of the Future Intern Fellowship, General Electric and McCormick School of Engineering and Applied Science, Northwestern University

Nelson Fellowship Award, Nelson Foundation and the Department of Ophthalmology & Visual Sciences, University of Illinois at Chicago

Whitaker Foundation Fellow

Fellow of Association for Research in Vision and Ophthalmology (FARVO-Silver)

Pan-American Association of Ophthalmology (PAAO) and Retina Research Foundation (RRF) Paul Kayser Global Award

Asia-Pacific Academy of Ophthalmology (APAO) Achievement Award

Fellow of Association for Research in Vision and Ophthalmology (FARVO-Gold)

Club Jules Gonin and Retina Research Foundation Award

Grants, Contracts and Funds

Principal Investigator: National Institute of Health (R01) (R01 EY029298). “Sustained Ocular Drug Delivery System for Anti-VEGF Agents”

Principal Investigator: National Institute of Health (R01) (R01 EY032222) “Dynamic Tracer Kinetic Model to Detect Preclinical Diabetic Retinopathy (DR)”

Co-Investigator: Center for Equine Health Research Grant, University of California, Davis “Pharmacokinetics and biocompatibility of a novel cyclosporine-loaded microsphere thermo-responsive hydrogel drug delivery system in horses”

Patents and Inventions

Biodegradable microsphere-hydrogel ocular drug delivery system (Patent No 10,980,882)

Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method (Patent No 11,266,608)